IVF Hartmann Operating Income Over Time
| VBSN Stock | CHF 137.00 2.50 1.79% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out IVF Hartmann Performance and IVF Hartmann Correlation. IVF |
Cross Equities Operating Income Analysis
Compare IVF Hartmann Holding and related stocks such as Coltene Holding AG, Newron Pharmaceuticals, and DocMorris AG Operating Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CLTN | 20.3 M | 12.2 M | 17 M | 19.4 M | 22.4 M | 20.4 M | 23.3 M | 25.5 M | 23.7 M | 32 M | 23.3 M | 43.8 M | 34.9 M | 19.6 M | 26.8 M | 30.9 M | 27.3 M |
| NWRN | (15.1 M) | (6.5 M) | (2.7 M) | (7.8 M) | (9.1 M) | (17.7 M) | (15.3 M) | (4.1 M) | (15 M) | (20.9 M) | (18.1 M) | (12.4 M) | (13.3 M) | (11.6 M) | 26.2 M | 30.1 M | 31.6 M |
| DOCM | 7.4 M | 5.2 M | 7.5 M | (11.3 M) | 8.2 M | 8.4 M | (7.1 M) | (21.2 M) | (31.4 M) | (45.7 M) | (117.6 M) | (197.5 M) | 40.5 M | (75.8 M) | (104.2 M) | (93.8 M) | (89.1 M) |
| ASCN | (45.2 M) | 40.6 M | 23.4 M | 44.8 M | 47.2 M | 28.7 M | 1.2 M | 33.2 M | 26.6 M | (8.6 M) | 11.3 M | 15.8 M | 14 M | 20.2 M | 7.6 M | 6.8 M | 6.5 M |
| SANN | (28.6 M) | (27.2 M) | (31.2 M) | (7.3 M) | (7.5 M) | 3.2 M | (33.1 M) | (50.5 M) | (51.4 M) | (10.4 M) | (53.1 M) | (56.9 M) | (52 M) | 68.8 M | (33.4 M) | (38.4 M) | (40.3 M) |
| BSLN | (62.8 M) | (57.3 M) | (50.8 M) | (33.3 M) | (41.8 M) | (61.5 M) | (43.9 M) | (14.1 M) | (23.2 M) | (17.2 M) | (23.3 M) | 1.2 M | 18.5 M | 19.2 M | 61.2 M | 51.6 M | 54.2 M |
| MOLN | 7.1 M | 7.1 M | 7.1 M | 7.1 M | 1.8 M | (2.2 M) | (19.5 M) | (25.8 M) | (37.4 M) | (36.7 M) | (58.3 M) | (63.4 M) | 116.6 M | (61.1 M) | (61.2 M) | (55.1 M) | (52.3 M) |
| SHLTN | 11.7 M | 4.2 M | (5.7 M) | 3.1 M | 1.3 M | (15.4 M) | (4.8 M) | 4.1 M | 12 M | 4.8 M | 396 K | (497 K) | (5.2 M) | (9 M) | (26.8 M) | (24.1 M) | (22.9 M) |
| ADXN | (20.9 M) | (31 M) | (27 M) | (14.5 M) | (1.8 M) | (3.9 M) | (3.1 M) | (3.2 M) | (1.4 M) | (14.8 M) | (12.2 M) | (15.5 M) | (20.5 M) | (2.2 M) | (2.8 M) | (3.2 M) | (3.3 M) |
IVF Hartmann Holding and related stocks such as Coltene Holding AG, Newron Pharmaceuticals, and DocMorris AG Operating Income description
Operating Income is the amount of profit realized from IVF Hartmann Holding operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of IVF Hartmann Holding is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| IVF Hartmann Holding | VBSN |
Specialization | Health Care, Health Care Equipment & Services |
| Business Address | Victor von Bruns-Strasse |
| Exchange | SIX Swiss Exchange |
CHF 137.0
Additional Tools for IVF Stock Analysis
When running IVF Hartmann's price analysis, check to measure IVF Hartmann's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IVF Hartmann is operating at the current time. Most of IVF Hartmann's value examination focuses on studying past and present price action to predict the probability of IVF Hartmann's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IVF Hartmann's price. Additionally, you may evaluate how the addition of IVF Hartmann to your portfolios can decrease your overall portfolio volatility.